COMBINED MESORIDAZINE AND AMANTADINE TREATMENT IN REFRACTORY SCHIZOPHRENICS

被引：0
|
作者：
OPLER, LA [1 ]
KAY, SR [1 ]
VITALHERNE, J [1 ]
机构：
[1] MONTEFIORE MED CTR, ALBERT EINSTEIN COLL MED, DEPT PSYCHIAT, BRONX, NY 10461 USA
来源：
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 1985年 / 37卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：318 / 325
页数：8
相关论文
共 50 条
  • [31] COMBINED TREATMENT FOR REFRACTORY ASCITES REINFUSION
    CONSOLO, F
    FERRAU, O
    PELLEGRINO, E
    BELLINGHIERI, G
    MILETO, G
    ARTIFICIAL ORGANS, 1984, 8 (02) : 255 - 255
  • [32] AN OPEN TRIAL OF GLYCINE AS AN ADJUNCT TO NEUROLEPTICS IN CHRONIC TREATMENT-REFRACTORY SCHIZOPHRENICS
    COSTA, J
    KHALED, E
    SRAMEK, J
    BUNNEY, W
    POTKIN, SG
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1990, 10 (01) : 71 - 72
  • [33] MESORIDAZINE AND CHLORPROMAZINE IN TREATMENT OF ALCOHOL WITHDRAWAL SYNDROME
    FROST, JB
    CANADIAN PSYCHIATRIC ASSOCIATION JOURNAL, 1973, 18 (05): : 385 - 387
  • [34] TRIFLUOPERAZINE AND TRANYLCYPROMINE IN CHRONIC REFRACTORY SCHIZOPHRENICS
    KRUSE, W
    AMERICAN JOURNAL OF PSYCHIATRY, 1960, 117 (06): : 548 - 549
  • [35] The Role of Amantadine Withdrawal in 3 Cases of Treatment-Refractory Altered Mental Status
    Fryml, Leah D.
    Williams, Kristen R.
    Pelic, Christopher G.
    Fox, James
    Sahlem, Gregory
    Robert, Sophie
    Revuelta, Gonzalo J.
    Short, Edward Baron
    JOURNAL OF PSYCHIATRIC PRACTICE, 2017, 23 (03) : 191 - 199
  • [36] AMANTADINE IN TREATMENT OF BENZTROPINE-REFRACTORY EXTRAPYRAMIDAL DISORDERS INDUCED BY ANTIPSYCHOTIC-DRUGS
    GELENBERG, AJ
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1978, 23 (03): : 374 - 380
  • [37] COMBINED USE OF METHIONINE AND CERTAIN PSYCHOTROPIC DRUGS IN TREATMENT OF CHRONIC SCHIZOPHRENICS
    MATVEYCH.TS
    SOVIET NEUROLOGY AND PSYCHIATRY-USSR, 1970, 3 (02): : 175 - &
  • [38] Amantadine for refractory "dyskinetic storm" in emergency room
    Ybot Gorrin, I.
    Vivancos Matellano, F.
    Diez Tejedor, E.
    MOVEMENT DISORDERS, 2009, 24 : S364 - S365
  • [39] REFINEMENT IN MEASUREMENT OF TREATMENT RESPONSE WITH COMBINED L-DOPA AND AMANTADINE IN PARKINSONISM
    KRAVITZ, EA
    HOLLMANN, TD
    JOURNAL OF CHRONIC DISEASES, 1974, 27 (11-1): : 563 - 572
  • [40] Effect of combined treatment with selective σ ligands and amantadine in the forced swimming test in rats
    Skuza, G
    Rogóz, Z
    POLISH JOURNAL OF PHARMACOLOGY, 2002, 54 (06): : 699 - 702
12345